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: IMPROVED PROCESS FOR THE PREPARATION OF 4-((4-METHYLPIPERAZIN-1-Y

IMPROVED PROCESS FOR THE PREPARATION OF 4-((4-METHYLPIPERAZIN1-YL)METHYL)-3-(TRIFLUOROMETHYL)ANILINE
The present invention relates to an improved process for the preparation of 4-((4methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline formula (1).
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Formula (1)
4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline

is

used

in

the

preparation of Ponatinib hydrochloride.
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Detailed description of the invention
The term "Solvent" used in the present invention refers to "hydrocarbon solvents"
such as n-hexane, n-heptane, cyclohexane, petroleum ether, benzene, toluene, xylene and the
like; "ether solvents" such as dimethyl ether, diisopropyl ether, diethyl ether, methyl tertbutyl ether, 1,2-dimethoxy ethane, tetrahydrofuran, Trifluoroacetic anhydride, 1,4-dioxane

15

and the like; "ester solvents" such as methyl acetate, ethyl acetate, isopropyl acetate, n-butyl
acetate, isobutyl acetate and the like; "polar-aprotic solvents such as dimethylacetamide,
dimethylformamide, dimethylsulfoxide, N-methylpyrrolidone and the like; "chloro solvents"
such as dichloromethane, dichloroethane, chloroform, carbon tetrachloride and the like;
"ketone solvents" such as acetone, methyl ethyl ketone, methyl isobutyl ketone and the like;
1
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"nitrile solvents" such as acetonitrile, propionitrile, isobutyronitrile and the like; “alcohol
solvents” such as methanol, ethanol, n- propanol, isopropanol, n-butanol, isobutanol, tbutanol, n-pentanol, isopentanol, 2-nitroethanol, ethylene glycol, 2-methoxyethanol, l, 2ethoxyethanol, diethylene glycol, 1, 2, or 3-pentanol, neo-pentyl alcohol, t-pentyl alcohol,
5

diethylene glycol monoethyl ether, benzyl alcohol, phenol, or glycerol and the like; “polaraprotic solvents" such as dimethylacetamide (DMA), dimethylformamide (DMF),
dimethylsulfoxide (DMSO), N-methylpyrrolidone (NMP) and the like; "polar solvents" such
as water or mixtures thereof.
As used herein the present invention, the term “base” is selected from inorganic bases
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like “alkali metal hydroxides” such as lithium hydroxide, sodium hydroxide, potassium
hydroxide and the like, “alkali metal carbonates” such as caesium carbonate, sodium
carbonate, potassium carbonate, lithium carbonate, rubidium carbonate and the like; “alkali
metal hydrides” such as sodium hydride, potassium hydride, lithium hydride and the like;
ammonia; and organic bases such as triethyl amine, methyl amine, ethyl amine,

15

diisopropylethylamine; “alkali metal alkoxides” such as sodium methoxide, sodium ethoxide,
sodium tert-butoxide, potassium ethoxide, potassium tert-butoxide thereof.
Abbreviations:
AIBN - Azobisisobutyronitrile
DBDMH - 1,3-Dibromo-5,5-dimethylhydantion
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In first embodiment, the present invention relates to an improved process for the
preparation of 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline formula (1),
comprising:
a) brominating the compound of 1-methyl-4-nitro-2-(trifluoromethyl)benzene formula
25

(3) in presence of AIBN, DBDMH, followed by coupling with 1-methylpepirazine
and treating the obtained compound with ethyl acetate hydrochloride to provide 1methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine

dihydrochloride

dihydrate

formula (2),

2
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b) reducing 1-methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine dihydrochloride
dihydrate formula (2) with Iron-ammonium chloride in the presence of methanol and
water
5

to

provide

4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline

formula (1),

wherein solvent and base used in step-a) and step-b) defined as above.
Further, 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline formula (1)
10

can be converted to Ponatinib hydrochloride according to any of the processes known in the
art.

The process described in the present invention was demonstrated in examples
illustrated below. These examples are provided as illustration only and therefore should not
15

be construed as limitation of the scope of the invention:

Examples
Example 1: Preparation of 1-methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine
dihydrochloride dihydrate formula (2).
3
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Acetonitrile (1000 ml) and was added to 1,3-dibromo-5,5-dimethylhydantoin (167.25
g) at 25-30°C and stirred for 10 minutes. Azobisisobutyronitrile (24 g) was added to the
above mixture at 25-30°C and stirred for 10 minutes. Heated the reaction mixture to 45-55°C
and stirred for 20 minutes. 1-methyl-4-nitro-2-(trifluoromethyl)benzene (50.0 g) formula (3)
5

and acetonitrile (200 ml) were added to the above mixture at 45-55°C. Heated the mixture to
70-80°C and stirred for 18 hours. Cooled the mixture to 25-30°C Sodium thiosulfate was
added to mixture and stirred for 20 minutes. Aqueous sodium carbonate solution was added
to the mixture at 25-30°C and stirred for 20 minutes. Methyl tert-butyl ether was added to the
mixture at 25-30°C and stirred for 30 minutes. Layers were separated and aqueous sodium
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chloride solution was added to the organic layer and stirred for 15 minutes.
Triethylamine (82.21 ml) was added to the organic layer and cooled the reaction
mixture to 10-15°C. 1-Methylpiperazine (21.66 ml) and methyl tert-butyl ether (25 ml) was
slowly added to the mixture at 10-15°C and stirred for 10 minutes. Raised the temperature of
the mixture to 25-30°C and stirred for 25 minutes. Aqueous sodium thiosulfate solution was
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added to the mixture and stirred for 25 minutes. Layers were separated. Cooled the organic
layer to 10-15°C and stirred for 10 minutes. Ethyl acetate hydrochloride solution was added
to the mixture at 10-15°C and stirred for 5 minutes. Raised the temperature of the mixture to
25-30°C and stirred for 40 minutes. Water was added to the mixture. Filtered the mixture
through hyflow bed and washed the bed with water. Layer were separated. Methyl tert-butyl

20

ether was added to aqueous layer at 25-30°C and stirred for 20 minutes. Layer were
separated. Aqueous sodium carbonate solution was added to the aqueous layer and stirred for
20 minutes. Methyl tert-butyl ether (250 ml) was added to aqueous layer at 25-30°C and
stirred for 20 minutes. Layer were separated. Cooled organic layer to 10-15°C and stirred for
10 minutes. Ethyl acetate hydrochloride was added to the organic layer and stirred for 2

25

hours. Filtered the solid and washed with methyl tert-butyl ether. Tetrahydrofuran (250 ml)
was added to the obtained compound. Heated the mixture to 45-55°C and stirred for 1 hour.
Cooled the mixture to 25-30°C and stirred for 1 hour. Filtered the solid and washed with
tetrahydrofuran and dried to get the title compound. Yield: 48 gms; 214.1°C-215.5°C.
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Example 2: Preparation of 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)
aniline formula (1).
Water (500 ml) was added to 1-methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)
piperazine dihydrochloride dihydrate (100 g) formula (2) at 25-30°8C and stirred for 10
5

minutes. Methanol (200 ml) and ammonium chloride (101.59) was added to the mixture at
25-30°C and stirred for 20-30 minutes. Cooled the temperature of the mixture to 10-15°C and
stirred for 30 minutes. Iron powder (36.5 g) was added to mixture at 10-15°C and stirred for
20 minutes. Raised the temperature of the mixture to 25-30°C and stirred for 6 hours. Neutral
carbon (5 g) was added to the mixture and stirred for 30 minutes. Filtered the mixture
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through hyflow bed and washed with water. Ethyl acetate (500 ml) was added to the mixture
at to 25-30°C and stirred for 10 minutes. Ammonia (300 ml) was added to the mixture and
stirred for 20 minutes. Filtered the mixture through hyflow bed and washed with ethyl
acetate. Layers were separated. Aqueous layer was extracted with ethyl acetate. Combined
the organic layers and washed with water. Carbon was added to the organic layer and filtered
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the mixture through hyflow bed and washed with ethyl acetate. Distilled the organic layer
and then co-distilled with a mixture of cyclohexane. Filtered the solid and washed with water.
Cyclohexane (500 ml) was added to the obtained solid. Heated the mixture to 50-55°C and
stirred for 2 hours. Cooled the mixture to 15-20°C and stirred for 4 hours. Filtered the
precipitated solid, washed with cyclohexane and dried to get the titled compound.
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Yield: 53 gms; M.R: 110°C-120.8°C.

**********
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